SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carlo Genova, Erika Rijavec, Giulia Barletta, Giovanni Burrafato, Federica Biello, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Angela Alama, Francesco Boccardo, Francesco Grossi, Afatinib for the treatment of advanced non-small-cell lung cancer, Expert Opinion on Pharmacotherapy, 2014, 15, 6, 889

    CrossRef

  2. 2
    Jie Luo, Xing-Rong Guo, Xiang-Jun Tang, Xu-Yong Sun, Zhuo-Shun Yang, Yong Zhang, Long-Jun Dai, Garth L. Warnock, Intravital biobank and personalized cancer therapy: The correlation with omics, International Journal of Cancer, 2014, 135, 7
  3. 3
    Mario Coccia, Path-breaking target therapies for lung cancer and a far-sighted health policy to support clinical and cost effectiveness, Health Policy and Technology, 2014, 3, 1, 74

    CrossRef

  4. 4
    Jihun Kim, Cameron Fox, Shouyong Peng, Mark Pusung, Eirini Pectasides, Eric Matthee, Yong Sang Hong, In-Gu Do, Jiryeon Jang, Aaron R. Thorner, Paul Van Hummelen, Anil K. Rustgi, Kwok-Kin Wong, Zhongren Zhou, Ping Tang, Kyoung-Mee Kim, Jeeyun Lee, Adam J. Bass, Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma, Journal of Clinical Investigation, 2014, 124, 12, 5145

    CrossRef